| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA3989769 | Neomycin sulfate | Inhibition index | = | 0.095 | ALA4303819 | Severe acute respiratory syndrome coronavirus 2 | |||||
| 2. | ALA3989769 | Neomycin sulfate | INH | = | 10.48 | % | ALA2166271 | % | Equus caballus | |||
| 3. | ALA3989769 | Neomycin sulfate | INH | = | -9.42 | % | ALA2166270 | % | Electrophorus electricus | |||
| 4. | ALA3989769 | Neomycin sulfate | Inhibition | = | 79.999 | % | ALA3039488 | % | Homo sapiens | |||
| 5. | ALA3989769 | Neomycin sulfate | Inhibition | = | 98.041 | % | ALA3039491 | % | Homo sapiens | |||
| 6. | ALA3989769 | Neomycin sulfate | Hepatotoxicity | 0 | ALA1697780 | no drug-induced liver injury reported | ||||||
| 7. | ALA3989769 | Neomycin sulfate | Hepatotoxicity | 0 | ALA1697779 | drug-induced liver injury reported | ||||||
| 8. | ALA3989769 | Neomycin sulfate | Hepatotoxicity | 0 | ALA1697778 | no drug-induced liver injury reported | ||||||
| 9. | ALA3989769 | Neomycin sulfate | Ratio | = | 0.125 | ALA1283854 | Pasteurella multocida | |||||
| 10. | ALA3989769 | Neomycin sulfate | MIC | = | 500 | ug ml-1 | ALA1283853 | ug.mL-1 | Pasteurella multocida | |||
| 11. | ALA3989769 | Neomycin sulfate | MIC | = | 1000 | ug ml-1 | ALA1283852 | ug.mL-1 | Pasteurella multocida | |||
| 12. | ALA3989769 | Neomycin sulfate | Ratio | = | 1 | ALA1283851 | Pasteurella multocida | |||||
| 13. | ALA3989769 | Neomycin sulfate | MIC | = | 125 | ug ml-1 | ALA1283850 | ug.mL-1 | Pasteurella multocida | |||
| 14. | ALA3989769 | Neomycin sulfate | MIC | = | 125 | ug ml-1 | ALA1283849 | ug.mL-1 | Pasteurella multocida | |||
| 15. | ALA3989769 | Neomycin sulfate | MIC | = | 125 | ug ml-1 | ALA1283848 | ug.mL-1 | Pasteurella multocida |
The page will load shortly, Thanks for your patience!